DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
7.24
-0.48 (-6.22%)
At close: Mar 12, 2026, 4:00 PM EDT
7.27
+0.03 (0.41%)
After-hours: Mar 12, 2026, 6:08 PM EDT
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $387.91 million as of March 12, 2026. Its market cap has increased by 51.70% in one year.
Market Cap
387.91M
Enterprise Value
332.86M
1-Year Change
51.70%
Ranking
Category
Stock Price
$7.24
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $387.91M, an increase of 956.97%. That is a compound annual growth rate of 38.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 402.00M | -3.02% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
| Dec 7, 2018 | 36.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sutro Biopharma | 400.68M |
| PureTech Health | 397.78M |
| Lineage Cell Therapeutics | 393.56M |
| Enanta Pharmaceuticals | 389.15M |
| Autolus Therapeutics | 388.57M |
| Armata Pharmaceuticals | 387.01M |
| Niagen Bioscience | 386.79M |
| Monopar Therapeutics | 384.92M |